| Recruiting | Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Admi Type 2 Diabetes Mellitus (T2DM) | Phase 1 | 2026-05-09 |
| Active Not Recruiting | A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P52 in Healthy Male Subjects Healthy Male Subjects | Phase 1 | 2026-01-26 |
| Completed | A Bioequivalence Study of CT-L02 Compared to Co-administration (CTL0201 and CTL0202) in Healthy Volunteers Healthy | Phase 1 | 2025-09-17 |
| Active Not Recruiting | Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects Healthy Participants | Phase 1 | 2025-09-17 |
| Completed | Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Admi Type 2 Diabetes Mellitus (T2DM) | Phase 1 | 2025-08-18 |
| Recruiting | A Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combina Refractory or Relapsed Multiple Myeloma | Phase 3 | 2025-08-12 |
| Recruiting | Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of A T2DM, Diabete Type 2, DM | Phase 3 | 2025-07-18 |
| Completed | A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P43 in Healthy Male Subjects Healthy Male Subjects | Phase 1 | 2025-05-30 |
| Active Not Recruiting | A Study to Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis Plaque Psoriasis | Phase 3 | 2025-05-26 |
| Active Not Recruiting | To Compare the Pharmacokinetics, Safety, and Immunogenicity of Subcutaneous CT-P6 and Herceptin in Healthy Mal Healthy | Phase 1 | 2025-03-25 |
| Recruiting | A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Non Squamous Non Small Cell Lung Cancer | Phase 3 | 2025-01-30 |
| Active Not Recruiting | A Phase 3 Study to Evaluate Efficacy & Safety of Subcutaneous CT-P13 in Patients With Moderate to Severe Activ Moderately to Severely Active Rheumatoid Arthritis | Phase 3 | 2025-01-03 |
| Active Not Recruiting | Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagli T2DM | Phase 3 | 2024-08-27 |
| Completed | To Compare the Pharmacokinetics, Safety and Immunogenicity of CT-P55 and Cosentyx in Healthy Subjects Healthy Male Subjects | Phase 1 | 2024-01-12 |
| Recruiting | A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients W Relapsing-remitting Multiple Sclerosis | Phase 3 | 2024-01-11 |
| Completed | A Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers Essential Hypertension | Phase 1 | 2023-06-02 |
| Unknown | A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid Arthr Rheumatoid Arthritis | Phase 3 | 2023-02-06 |
| Active Not Recruiting | A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis | — | 2023-01-13 |
| Unknown | Compare the Auto-injector and Pre-filled Syringe of CT-P47 in Healthy Subjects Healthy Subjects | Phase 1 | 2022-11-15 |
| Completed | To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Ch Moderate to Severe Chronic Plaque Psoriasis | Phase 3 | 2022-11-07 |
| Completed | A Bioequivalence Study of L04TD2 Compared to Administration of L04RD1 in Healthy Volunteers Healthy | Phase 1 | 2022-09-30 |
| Completed | A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 3 | 2022-09-14 |
| Completed | A Bioequivalence Study of L04TD1 Compared to Administration of L04RD1 in Healthy Volunteers Healthy | Phase 1 | 2022-09-01 |
| Completed | A Food Effect Study of CT-L01 After Oral Administration in Healthy Volunteers Healthy | Phase 1 | 2022-07-09 |
| Completed | Study to Evaluate and Compare the Efficacy and Safety of AZM and AML Combined and Alone in Mild-to-moderate Es Essential Hypertension | Phase 3 | 2022-07-08 |
| Completed | A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 12.5 mg and MET XR 500 mg) in Healthy Volu Healthy | Phase 1 | 2022-06-25 |
| Completed | A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 25 mg and MET XR 1,000 mg) in Healthy Volu Healthy | Phase 1 | 2022-06-11 |
| Withdrawn | To Evaluate the Safety and Efficacy of Inhaled CT-P63 and CT-P66 Combination Therapy in Symptomatic Patients W COVID-19 | Phase 3 | 2022-04-01 |
| Unknown | A Study to Compare the Pharmacokinetics and Safety of CT-P47 and RoActemra in Healthy Subjects Healthy Subjects | Phase 1 | 2021-12-22 |
| Completed | To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy Subjects SARS-CoV-2 Infection | Phase 1 | 2021-10-11 |
| Completed | Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Pro Healthy Subject | Phase 1 | 2021-10-06 |
| Completed | A Drug-Drug Interaction Study of CTL0901 and CTL0902 Compared to Coadministration in Healthy Adult Volunteers Health, Subjective | Phase 1 | 2021-07-23 |
| Completed | A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult Volunteers Health, Subjective | Phase 1 | 2021-07-23 |
| Completed | Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edem Diabetic Macular Edema (DME) | Phase 3 | 2021-07-22 |
| Completed | A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis Postmenopausal Women With Osteoporosis | Phase 3 | 2021-06-17 |
| Completed | A Study to Compare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque Psoriasis Psoriasis | Phase 3 | 2021-01-11 |
| Completed | To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria Chronic Spontaneous Urticaria | Phase 3 | 2020-12-09 |
| Terminated | A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subject Cardiomyopathy, Hypertrophic Obstructive | Phase 1 | 2020-10-23 |
| Completed | A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male S Healthy Male Subjects | Phase 1 | 2020-10-20 |
| Completed | A Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 I SARS-CoV-2 Infection | Phase 2 / Phase 3 | 2020-10-05 |
| Completed | This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Sympt SARS-CoV-2 Infection | Phase 1 | 2020-09-04 |
| Completed | CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Coli Ulcerative Colitis | Phase 3 | 2020-09-01 |
| Completed | Study to Compare PK and Safety of Subcutaneous Injection of Ustekinumab and CT-P43 in Healthy Subjects Healthy Subjects | Phase 1 | 2020-08-03 |
| Completed | To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects SARS-CoV-2 Infection | Phase 1 | 2020-07-18 |
| Completed | To Compare the PK and Safety of Omalizumab (CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy Sub Healthy | Phase 1 | 2020-05-28 |
| Completed | CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease Crohn's Disease | Phase 3 | 2019-10-28 |
| Completed | A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthr Rheumatoid Arthritis | Phase 3 | 2019-09-09 |
| Completed | To Compare the Pharmacokinetics and Safety of the Auto-injector and Pre-filled Syringe of CT-P17 Healthy | Phase 1 | 2019-06-21 |
| Completed | To Compare the Pharmacokinetics and Safety of CT-P17 and Humira in Healthy Subjects Healthy | Phase 1 | 2019-05-31 |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 or CT-G11 and Food Effect of CT-G20 in H Healthy | Phase 1 | 2019-04-08 |
| Completed | To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metas Adenocarcinoma of Lung | Phase 3 | 2019-02-01 |
| Completed | A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis Rheumatoid Arthritis | Phase 3 | 2018-11-26 |
| Completed | To Compare the Efficacy, Pharmacokinetics and Safety Between CT-P13 and China Approved Remicade When Co-admini Rheumatoid Arthritis | Phase 3 | 2018-11-12 |
| Completed | CT-P13 (Infliximab) Subcutaneous Administration by Pre-filled Syringe and Auto-injector in Healthy Subjects Health, Subjective | Phase 1 | 2018-02-21 |
| Completed | To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licens Healthy | Phase 1 | 2017-08-07 |
| Terminated | A Study to Evaluate the Efficacy and Safety of CT-P27 in Acute Uncomplicated Influenza A Infection Influenza A | Phase 2 | 2016-12-09 |
| Completed | A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Acti Crohn's Disease, Ulcerative Colitis (Part 2 Only) | Phase 1 | 2016-09-29 |
| Completed | A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Activ Rheumatoid Arthritis | Phase 3 | 2016-09-12 |
| Completed | Study Comparing Pharmacokinetics, Safety and Immunogenicity of CT-P6 and US-licensed Herceptin Healthy Volunteers | Phase 1 | 2015-12-01 |
| Completed | To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lympho Follicular Lymphoma | Phase 3 | 2015-11-09 |
| Terminated | An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis Ankylosing Spondylitis | — | 2015-05-26 |
| Terminated | To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (U Crohn's Disease, Ulcerative Colitis | — | 2014-12-08 |
| Completed | Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's Disease Crohn's Disease | Phase 3 | 2014-09-19 |
| Completed | PK Similarity Prospective Phase 3 Study in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 3 | 2014-08-01 |
| Completed | To Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparison With Ri Lymphoma, Follicular | Phase 3 | 2014-07-14 |
| Completed | Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast Cancer HER2-positive Carcinoma of Breast | Phase 3 | 2014-06-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model Influenza A | Phase 2 | 2014-02-15 |
| Terminated | An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA Rheumatoid Arthritis | — | 2013-12-17 |
| Completed | Long-Term Efficacy and Safety of CT-P10 in Patients With RA Rheumatoid Arthritis | Phase 1 | 2013-05-01 |
| Completed | An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis | Phase 1 | 2012-03-01 |
| Completed | An Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexa Rheumatoid Arthritis | Phase 3 | 2012-03-01 |
| Terminated | Provide Initial Evidence of Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy to Support the Pivotal CT Diffuse Large B-Cell Lymphoma | Phase 1 | 2012-02-01 |
| Completed | Demonstrate the Equivalence of CT-P10 to MabThera With Respect to the Pharmacokinetic Profile in Patients With Rheumatoid Arthritis | Phase 1 | 2012-02-01 |
| Completed | Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS) Ankylosing Spondylitis | Phase 1 | 2010-10-01 |
| Completed | Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA) Rheumatoid Arthritis | Phase 3 | 2010-10-01 |
| Completed | Demonstrate Efficacy and Safety of Metastatic Breast Cancer Metastatic Breast Cancer | Phase 3 | 2010-06-01 |
| Completed | Evaluate Safety, Efficacy and Pharmacokinetics Metastatic Breast Cancer | Phase 1 / Phase 2 | 2010-02-01 |